ARCAPTA NEOHALER (indacaterol inhalation powder) 75 mcg capsules
by Novartis Pharmaceuticals Corporation

Bronchospasm prevention with COPD
Prevention of bronchospasm with chronic bronchitis
Prevention of bronchospasms with emphysema
75 mcg capsule with inhalation device
Inhale the contents of one capsule (75 mcg) by inhalation route once daily

Bronchospasm prevention with COPD
Dosage Type: Capsule, with inhalation device
Inhale the contents of one capsule (75 mcg) by inhalation route once daily

Prevention of bronchospasm with chronic bronchitis
Inhale the contents of one capsule (75 mcg) by inhalation route once daily

Prevention of bronchospasms with emphysema
Inhale the contents of one capsule (75 mcg) by inhalation route once daily
Rarely, serious (sometimes fatal) breathing problems have happened to people with asthma using a long-acting inhaled beta agonist (salmeterol). Since indacaterol is similar to salmeterol, it might cause these serious breathing problems. Indacaterol has not been shown to be safe or effective to treat asthma and is not approved for this use. Talk with your doctor about the risks and benefits of treatment with this medication.
Severe Warnings
Congenital long QT syndrome
Hypokalemia
Prolonged QT interval
Contraindicated
Acutely deteriorating asthma
Moderate Warnings
Cardiac arrhythmia
Chronic myocardial ischemia
Diabetes mellitus
Hypertension
Seizure disorder
Thyrotoxicosis
Less Frequent
Severe
Chest pain
Diabetes mellitus
Sinusitis

Less Severe
Cramps
Diarrhea
Dizziness
Dyspnea
Insomnia
Muscle spasm
Myalgia
Nausea
Peripheral edema
Skin rash
Sore throat
Upper respiratory infection
More Frequent
Severe
Pharyngitis

Less Severe
Cough
Headache disorder
Hypertension
Rare / Very Rare
Severe
Angina
Asthma exacerbation
Atrial fibrillation
Cardiac arrhythmia
Hyperglycemia
Hypokalemia
Paradoxical bronchospasm
Pneumonia
Prolonged QT interval
Tachyarrhythmia

Less Severe
Dyspepsia
Palpitations
Pruritus of skin
More information
Contraindicated
None

Severe Precaution
Indacaterol
1 Day – 18 Years
No safety and efficacy established. Not indicated for asthma.

Management or Monitoring Precaution
None
Indacaterol
Severity Level: C
Additional Notes: Insufficient human data available

More information
Contraindicated
None

Precaution Exists
Indacaterol
GeneralExcretion PotentialEffect on InfantNotes
Evaluate use carefullyUnknownNot known; no or inclusive dataInsufficient human data, excreted in rats

No Known Risk
None
More information
No precaution information has been provided for this patient type.
Bronchospasm prevention with COPD
J44Other chronic obstructive pulmonary disease
J44.9Chronic obstructive pulmonary disease, unspecified
Prevention of bronchospasm with chronic bronchitis
J44Other chronic obstructive pulmonary disease
J44.9Chronic obstructive pulmonary disease, unspecified
J44 Other chronic obstructive pulmonary disease
J44 Other chronic obstructive pulmonary disease
J44.9 Chronic obstructive pulmonary disease, unspecified
J44.9 Chronic obstructive pulmonary disease, unspecified

Data included with permission and copyrighted by First DataBank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgement of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. Diagnosis codes are provided for reference only. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatement.